Regulation & Governance

91. Any rider under the course of medical treatment prescribed or administered by a medical practitioner for recognised medical purposes shall, prior to the commencement of trackwork or a race meeting in which he is riding, make full disclosure in the approved form to the Stipendiary Stewards of such prescription or administration. The same duty of disclosure shall apply where any medication is obtained from any pharmacy and used as ‘self-prescribed’ medication.

92. Any jockey or Rider who, in the opinion of the Stipendiary Stewards: –

 (a)    at the time he presents himself for a race or trackwork, is found to be under the influence of a banned substance;

(b)     delivers a sample as directed by the Stipendiary Stewards or any person duly delegated by them and which upon analysis is found to contain a banned substance; (c)         refuses or fails to deliver a sample as directed by the Stipendiary Stewards or any person duly delegated by them, or tampers with, adulterates, alters, substitutes or in any way hinders the collection of such sample or attempts to do any of those things;

(d)     without reasonable excuse, refuses or fails to deliver a sample of the urine or of his breath when directed to do so, or tampers with or in any way hinders the collection of such sample, the Stewards may forthwith, pending the determination of an inquiry or other proceeding or the result of any other analysis, order that the said jockey or rider be stood down from riding for the remaining part of the race meeting;

(e)     without reasonable excuse, fails to provide a sample when required to do so in pursuance of this Rule, shall be informed that his failure to provide such sample may be used against him as prima facie evidence that at the material time he was under the influence of a banned substance under the Rules in any subsequent inquiry for a breach of the Rules of Racing;

(f)     without reasonable excuse, fails to provide a sample when required to do so in

pursuance of this Rule may, upon conviction, be liable to any penalties provided under Rule 11(d). In the case of a second or subsequent conviction, the offender under paragraph (c) shall be liable to a disqualification for a period of not less than 2 years;

(g)     has incurred a penalty under any subparagraph of rule 92 shall not be allowed to participate in any race or track work unless a sample of his urine or otherwise, as

directed by the Stipendiary Stewards, shows, upon analysis, that it is clear of any prohibited substance;

(h)     fails to provide a sample of urine within a reasonable period of time following the requirement for its provision being made; and/or

(i)     fails to comply with any directive, decision, direction, ruling or order of the Stipendiary Stewards;

shall commit an offence and be liable to any of the penalties provided in Rule 11(d) and shall also be stood down for the remainder of the race meeting at the discretion of the Stipendiary Stewards.

93. Upon written application by the rider at the time of the taking of any sample, the Club shall split it into two which shall be marked ‘A sample’ and ‘B sample’ respectively. If upon analysis of the ‘A sample’ a prohibited substance is detected therein, the rider may request that the ‘B sample’ be analysed for such substance by such other laboratory as may be designated and/or approved by the HRD. In the latter case, the ‘B sample’ shall be despatched to such designated laboratory through the Security Official appointed by the HRD or his representative and the rider shall be liable for all the costs of the analysis including those incurred to despatch the ‘B sample’ to such designated laboratory.

The provisions of Rule 259 shall apply ‘mutatis mutandis’ to any analysis under Rule 93.

94. For the purpose of this Rule, a banned substance means the following psycho-active substances –

(a)     Alcohol – at or above a screening limit of 10 micrograms of ethanol per 100 millilitres of breath or 20 milligrams of ethanol per 100 millilitres of blood;

(b)     Amphetamines and amphetamine-like substances including the “Ecstacy” group and excluding Pseudoephedrine and Phenylpropanolamine;

(c)     Barbiturates;

(d)     Benzodiazepines and Benzodiazepine-like substances;

(e)     Cannabinoids and/or Synthetic cannabinoids and/or — at or above a screening limit of 15 nanograms of delta-9-tetrahydro-11-nor-cannabinol-9-carboxylic acid per milliliter in urine;

(f)     Cocaine;

(g)     Clenbuterol, Benzylpiperazine, Ketoamphetamines, Cathinone and their derivatives or other similar substances, whether naturally occurring, synthetic or semi-synthetic;

(h)     Ephedrine — at or above a screening limit of 10 micrograms of ephedrine per millilitre in urine;

(i)     Ketamine and Tiletamine;

(j)     Lasix (Furosemide) and other diuretics;

(k)     Lysergic Acid Diethylamide (LSD);

(l)     Methyl ephedrine — at or above a screening limit of 10 micrograms of         methyl ephedrine per millilitre in urine;

(m)   Methylphenidate;

(n)     Opioids, excluding the normal use of Codeine with a screening limit of 2000 nanograms per millilitre, Dextromethorphan, Dihydrocodeine, Ethyl morphine, Pholcodine, Propoxyphene and Tramadol;

(o)     Phencyclidine;

(p)     Masking Agents;

(q)     Tryptamine derivatives.